Results 1 to 10 of about 45,307 (50)
Nan Mei,1,* Sha Gong,1,* Lizhao Wang,2 Lu Wang,1 Jincheng Wang,1 Jianpeng Li,3 Yingying Bao,4 Huanming Zhang,1 Huaiyu Wang1 1Department of Hematology, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, People’s ...
Mei N +8 more
doaj
Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations
Chronic myelomonocytic leukemia (CMML) is an aggressive clonal stem cell disorder categorized amongst myelodysplastic/myeloproliferative (MDS/MPN) overlap neoplasms.
Ludovica Marando +2 more
doaj +1 more source
Circulating microRNAs targeting coagulation and fibrinolysis in patients with severe COVID-19
Background Coronavirus-19 disease (COVID-19) frequently causes coagulation disturbances. Data remains limited on the effects of microRNAs (miRNAs) on coagulation during COVID-19 infection.
Tuukka A. Helin +4 more
doaj +1 more source
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis
Sarcoidosis, a multi-organ system disease, often presents insidiously. Thrombocytopenia in sarcoidosis is frequent because of hypersplenism, granulomas infiltrating the bone marrow, or immune thrombocytopenia (ITP).
Dorela Lame +5 more
doaj +1 more source
Plasmacytoma in the Maxillary Jaw: A Diagnostic and Therapeutic Challenge
Plasmacytoma is a neoplastic disorder originating from plasma cells, with bone and soft tissue being common sites of manifestation. This report presents the clinical and radiological findings of a 65-year-old female patient who presented with an ...
Sara Bernardi +5 more
doaj +1 more source
We report two cases of pancytopenia in patients after recovering from a mild COVID-19, now presenting as paroxysmal nocturnal hemoglobinuria (PNH) and aplastic anemia.
Jeff Justin Aguilar +2 more
doaj +1 more source
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study
Mantle cell lymphoma (MCL) prognosis has significantly improved in recent years; however, the possible survival benefit of new treatment options should be evaluated outside of clinical trials. We investigated 73 consecutive MCL patients managed from 2006
Emanuele Cencini +8 more
doaj +1 more source

